Pyxis Oncology


Pyxis Oncology is advancing a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to help patients suffering from difficult-to-treat cancers.

Industries

Employees

11-50

Links


Org chart

Lara S. Sullivan
Chief Executive Officer
Collapse
Michael Bui
Senior Vice President, Head Of Global Regulatory Affairs
Jitu Wadhane
Principal Financial And Accounting Officer
Donna Regalado
Senior Director, Human Resources
Stephen Worsley
Chief Business Officer
Stan Szpindor
Vice President, R&d Quality
Alex Kane
Senior Vice President

Board & advisors